RT Journal Article
SR Electronic
T1 First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 120
DO 10.1186/s40425-019-0600-6
VO 7
IS 1
A1 Zhou, Yixin
A1 Lin, Zuan
A1 Zhang, Xuanye
A1 Chen, Chen
A1 Zhao, Hongyun
A1 Hong, Shaodong
A1 Zhang, Li
YR 2019
UL http://jitc.bmj.com/content/7/1/120.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.